Kenneth More YOU? Author Swipe

Last 10y

Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer Open

Christopher Gallagher, Kenneth More, Tripthi Kamath, Anthony Masaquel, Annie Guérin , et al. · 2016

Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice Open

Christopher Gallagher, Kenneth More, Anthony Masaquel, Tripthi Kamath, Annie Guérin , et al. · 2016